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A preliminary survey of the first 200 patients indicated that there was a reasonable chance (88%) of detecting transient disturbances of rhythm because of the long periods during which the patients remained under observation (up to 31 days).
The arrhythmia was discovered during routine transmissions and was unrelated to symptoms in only 22 patients (19%), while in all others the detected arrhythmias were accompanied by those complaints for which they were referred. In this respect, the telephone transmitting system was no worse than the Holter technique, which detects arrhythmias even if they are symptomless. Nevertheless, if the complaints are of too short duration or the arrhythmia renders the patient unable to make the necessary telephone call the Holter technique is preferable, provided the dysrhythmia occurs on the day of monitoring.
The immediate analysis and corresponding therapeutic measures that were taken in the six patients in whom multifocal ventricular ectopic beats or short runs of ventricular tachycardia were detected could not have been carried out with the Holter technique since the scanning in this method is always retrospective. In these cases, the telephone monitoring is obviously more efficient and practical.
Another point in favour of the telephone transmission is the convenience of evaluating the effectiveness of antiarrhythmic treatment given. The repeated contact with the medical personnel during the day allows optimal adjustment of drug doses at short intervals without the patient having to attend the outpatient clinic. Safe ambulatory withdrawal of antiarrhythmic treatment can likewise be supervised by the same method.
The results in patients in whom chest pain was considered ischaemic were rather disappointing. A definite electrocardiographic change during pain was discovered in less than a third of the patients, while in the other patients the ST-T changes were not of diagnostic value. In eight ofthe 32 patients suspected of having angina pectoris the symptoms were accompanied by rhythm disturbances but not by diagnostic ST-T changes. The complaints disappeared on successful treatment of the dysrhythmia.
Another important aspect of this type of patient surveillance is that it helps to exclude the existence of significant cardiac rate or rhythm disturbances in patients suffering from symptoms resembling cardiac arrhythmia. If recordings are normal when symptoms are present unnecessary medication can be prevented and the patient can be reassured. In many such patients symptoms disappeared after they were reassured. In patients with chronic renal failure (CRF) reports of increased VIIIC3 and increased levels of VIIIRA4 conflict with reports of decreased glass bead platelet retention5 6 and prolonged bleeding time.7 In the hope of clarifying this apparent discrepancy we investigated the factor VIII complex components in patients with CRF who were either conservatively treated or on haemodialysis and explored the fate of these components in kidney transplant recipients.
Patients and methods
Thirty patients with CRF due to various primary renal diseases who had undergone maintenance haemodialysis for six months to six years were studied immediately before a routine dialysis and, in 10 of them, immediately after dialysis as well. Blood samples from five patients with conservatively treated severe CRF (serum creatinine ranging from 796 to 1149 ,imol/l (9-13 mg/100 ml) ) were also studied.
Nine patients with renal transplants were also examined at least twice during the first five weeks after transplantation (37 blood samples). All had cadaver kidney transplants matched for two or three HLA antigens. All donor-recipient lymphocytotoxic cross matches were negative. All the patients were given heparin during the first weeks after transplantation and azathioprine and corticosteroids throughout, according to a standard procedure. Four blood samples were obtained from two patients undergoing early irreversible hyperacute rejection. Twenty-two samples were examined from four patients in whom an acute reversible rejection was the only complication during these five weeks of transplantation. During the same period the remaining three patients (11 samples) had acute reversible rejection with either infection or urological complications, or both.
Control samples were taken from 13 patients with normally functioning grafted kidneys six months to five years after transplantation and from six patients whose grafts had been removed after hyperacute rejection and who had been undergoing redialysis for six months to two years.
Twenty-seven normal subjects matched for age and sex were also studied.
Blood was collected in 3 80' citrate solution (nine parts of blood for one part anticoagulant solution). Platelet-poor plasma was obtained after centrifugation at 3000 g for 20 minutes at 12°C and was stored at -30 C.
VIIIC was tested by a one-stage assay on freshly collected plasma. VIIIRA was measured by unidimensional immunoelectrophoresis according to the method of Laurell8 modified as described.9 Antiserum was obtained after immunisation of a rabbit with purified human factor VIII according to the method of Marchesi et al. 10 The plasma cofactor of ristocetin-induced platelet aggregation (VIIIVWF) was measured by a modification9 of the quantitative assay of Weiss et VIIIC (228±160%), VIIIRA (187+101%), and VIIIVWF (144-1±+709%) remained increased in patients who had undergone a hyperacute rejection and were back on maintenance haemodialysis; the results were significantly different from those in the patients with CRF on haemodialysis (for VIIIvWf t=5-5; P<0.01). The VIIIRA: VIIIVWF ratio in these patients was 1-2.
Discussion
Our results confirm the increase in VIIIC and VIIIRA already reported in CRF.3 The striking finding was the association of an increase of these two values with a decrease in VIIIVWF levels. This abnormality is no longer found in patients with normally functioning grafted kidneys after the sixth month after transplantation.
This decrease in VIIIVWF has already been suggested by Hellem et al,5 Salzman and Neri,6 and Castaldi et al," who showed decreased platelet retention on glass beads in CRF. To the best of our knowledge this has not been reported when BRITISH MEDICAL JOURNAL 11 SEPTEMBER 1976 the quantitative method of Weiss,2 measuring the plasma activity responsible for ristocetin-induced platelet aggregation, has been used. Thus, if the VIIIRA:VIIIC ratio approximates to 1, suggesting a normal association of VIIIRA with the part of the molecule associated with clotting activity in patients with CRF, the VIIIRA:VIIIVWF ratio is considerably increased; this suggests the presence of a partially non-functional protein for the VIIIVWF activity. The increase in VIIIRA:VIIIVWF ratio is not related to any specific type of renal disease. It is found in conservatively treated as well as haemodialysed CRF patients, but it is not yet known at what stage of renal failure it appears. Dialysis did not improve the ratio and the ratio did not differ in short-term or long-term haemodialysed patients; it has been reported that platelet adhesiveness is often unchanged after dialysis and the Ivy bleeding time occasionally shortened. 3 We suggest that the low VIIIVWF level partly explains the prolonged bleeding time and the bleeding tendency found in many patients with CRF.6 7 It seems to be a more plausible explanation than the different thrombocytopathies reported in uraemia by several workers, although these may also be contributory when they are present. Impaired platelet aggregation with adenosine diphosphatell 12 and with thrombin6 12 is not always found in uraemia, and platelet factor 3 abnormalities in uraemic platelets7 13 are more likely to interfere with the coagulation mechanism than with primary haemostasis.
In all the transplanted patients studied during the first five weeks of transplantation, the VIIIRA :VIIIVWF ratio remained increased (2 6), although VIIIRA and VIIIVWF values were higher than in CRF. This suggests, as in CRF, the presence of a non-functional protein in these patients. Moreover, in the transplant recipients in whom an acute reversible rejection had been the only untoward event during that period the VIIIRA: VIIIVWF ratio was even higher (3) (4) (5) (6) (7) (8) . The difference may be explained by the various degrees of increase of VIIIC, VIIIRA, and VIIIVWF in patients with additional infection or septicaemia.' Strikingly high levels of VIIIC, VIIIRA, and VIIIVWF with a normal VIIIRA:VIIIVWF ratio (0 97) (see table) were obtained in two patients undergoing early irreversible hyperacute rejection. The thrombogenic role of such an excess of functionally normal factor VIII protein may be questioned. Both VIIIC and VIIIVWF as well as VIIIRA remained high in patients whose grafts had been removed after hyperacute rejection and who were back on maintenance haemodialysis. The VIIIRA: VIIIVWF ratio was normal. This very different result from that obtained in the haemodialysis group may suggest that in the same patients it could be a predisposing factor to thrombogenesis and hyperacute rejection, and it would be interesting to investigate what would happen in such patients when they are transplanted.
It has recently been shown that endothelial cells synthesise and release a factor VIII containing the same polypeptide subunit present in plasma VIIIRA and having a VIIIVWF biological activity.'5 VIIIRA has been shown by immunofluorescent microscopy to be present in the endothelial cells of glomeruli, peritubular capillaries, arteries, and veins of normal kidneys.'6 Possibly, therefore, the increase in VIIIRA protein in the transplanted patients is a direct reaction to vascular damage occurring in the graft, but no explanation can be provided for the high VIIIRA level found in CRF.
At least three hypotheses can be proposed to explain the decrease in VIIIVWF in CRF patients. the start of the study there seemed to be at least three reasons why such a study might be valuable. Firstly, it would enable the normal range of variation in the neonatal ECG to be assessed more accurately. This assessment would be based on statistical analysis and follow-up of many normal and abnormal records. Secondly, it would determine whether a routine neonatal ECG could be useful in the early detection of congenital heart disease. FinalJy, it would establish prospectively whether there is a relation between conduction abnormalities, especially pre-excitation, and the sudden infant death syndrome (cot deaths).
Although the study is continuing, the results in the first year bore out some of these expectations, and we report them here.
Patients and methods
From April 1975 to April 1976 818 babies who were kept in the local miaternity unit for nine days after delivery were screened. The 3500 of babies discharged at 48 hours were not included.
Standard ECGs were recorded using the portable Hewlett Packard machine Model 1504A. The usual paediatric plate electrodes were strapped to each limb and disposable Dracard electrodes were used for the chest leads. In addition to the limb leads, Vl, V2, V4, and V6 were recorded; more recently VR4 was added.
ECGs were recorded between the 7th and 10th day of life to exclude some of the haemodynamic changes that occur in the first week, during the transition from the fetal to the infant circulatory pattern.
To minimise the mothers' anxiety we told them about the test, explaining that the baby would feel no discomfort and that the procedure was completely safe and designed to supplement the routine clinical examination of the heart. The mother was told the result on the same day, only unequivocal abnormalities being mentioned. All infants with a definite ECG abnormality, together with those with any questionable anomaly or an "innocent murmur," were referred for follow-up, together with an equal number of randomly selected babies with normal ECGs to act as controls. The general practitioner was told of any significant abnormalities. The baby was usually seen for follow-up between 6 and 8 weeks of age, but he was seen earlier if an abnormality needed more careful evaluation. There was a high rate of attendance. Only eight babies failed to return, and all were alive and well at the time of writing.
Preterm babies and those of low birth weight were also included in the series because they have a higher incidence of cot death.' 2 The criteria for normality in the ECGs of these infants are slightly different from those for term babies.
